高血壓 高尿酸 慢性腎病 胰島素 https://2019medicinenote.blogspot.com/2019/12/blog-post_57.html . 糖尿病相關筆記~目錄 https://2019medicinenote.blogspot.com/2020/01/blog-post_4.html

2020年4月27日 星期一

野外與登山醫學----21---WMS 2019 update HAPE PREVENTION Nifedipine 21

Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update
統一名詞翻譯
AMS 急性高山病
HACE 高海拔腦水腫
HAPE 高海拔肺水腫
acute altitude illness 急性高海拔疾病

Nifedipine
A single, randomized, placebo-controlled study83 and extensive clinical experience have established a role for nifedipine in HAPE prevention in susceptible individuals. The recommended dose is 30 mg of the extended-release preparation administered every 12 h. Hypotension was not noted in the study83 and is generally not a concern with the extended-release version of the medication but may occur in a limited number of individuals. Recommendation. Nifedipine is recommended for HAPE prevention in HAPE-susceptible people. Recommendation Grade: 1B

沒有留言:

張貼留言

幼兒專責醫師-新生兒黃疸

2026-03-26 09:16AM 衛生福利部-幼兒專責醫師實務參考手冊電子版 圖片: 台灣新生兒科醫學會-新生兒延長性黃疸處置建議 2018.05.04 測定『直接及總膽紅素並求其比值』:當新生兒的黃疸超過出生後 14 天時,建議於 30 天大之前,至少檢測一次血中直接及總膽...